1248 related articles for article (PubMed ID: 9233789)
1. beta-catenin is a target for the ubiquitin-proteasome pathway.
Aberle H; Bauer A; Stappert J; Kispert A; Kemler R
EMBO J; 1997 Jul; 16(13):3797-804. PubMed ID: 9233789
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
Hagen T; Vidal-Puig A
Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
[TBL] [Abstract][Full Text] [Related]
3. Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system.
Sadot E; Simcha I; Iwai K; Ciechanover A; Geiger B; Ben-Ze'ev A
Oncogene; 2000 Apr; 19(16):1992-2001. PubMed ID: 10803460
[TBL] [Abstract][Full Text] [Related]
4. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
[TBL] [Abstract][Full Text] [Related]
5. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
[TBL] [Abstract][Full Text] [Related]
6. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
Jho Eh; Lomvardas S; Costantini F
Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
[TBL] [Abstract][Full Text] [Related]
7. Posttranscriptional regulation of alpha-catenin expression is required for Wnt signaling in L cells.
Takahashi N; Ishihara S; Takada S; Tsukita S; Nagafuchi A
Biochem Biophys Res Commun; 2000 Nov; 277(3):691-8. PubMed ID: 11062015
[TBL] [Abstract][Full Text] [Related]
8. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
9. Axin prevents Wnt-3a-induced accumulation of beta-catenin.
Kishida M; Koyama S; Kishida S; Matsubara K; Nakashima S; Higano K; Takada R; Takada S; Kikuchi A
Oncogene; 1999 Jan; 18(4):979-85. PubMed ID: 10023673
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of beta-catenin by activated p53.
Sadot E; Geiger B; Oren M; Ben-Ze'ev A
Mol Cell Biol; 2001 Oct; 21(20):6768-81. PubMed ID: 11564862
[TBL] [Abstract][Full Text] [Related]
11. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells.
Papkoff J; Aikawa M
Biochem Biophys Res Commun; 1998 Jun; 247(3):851-8. PubMed ID: 9647782
[TBL] [Abstract][Full Text] [Related]
12. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
[TBL] [Abstract][Full Text] [Related]
13. Identification of two novel regulated serines in the N terminus of beta-catenin.
van Noort M; van de Wetering M; Clevers H
Exp Cell Res; 2002 Jun; 276(2):264-72. PubMed ID: 12027456
[TBL] [Abstract][Full Text] [Related]
14. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
[TBL] [Abstract][Full Text] [Related]
15. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K
Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688
[TBL] [Abstract][Full Text] [Related]
16. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
Christian SL; Sims PV; Gold MR
J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
[TBL] [Abstract][Full Text] [Related]
17. Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system.
Salomon D; Sacco PA; Roy SG; Simcha I; Johnson KR; Wheelock MJ; Ben-Ze'ev A
J Cell Biol; 1997 Dec; 139(5):1325-35. PubMed ID: 9382877
[TBL] [Abstract][Full Text] [Related]
18. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A.
Seeling JM; Miller JR; Gil R; Moon RT; White R; Virshup DM
Science; 1999 Mar; 283(5410):2089-91. PubMed ID: 10092233
[TBL] [Abstract][Full Text] [Related]
19. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin.
Kitagawa M; Hatakeyama S; Shirane M; Matsumoto M; Ishida N; Hattori K; Nakamichi I; Kikuchi A; Nakayama K; Nakayama K
EMBO J; 1999 May; 18(9):2401-10. PubMed ID: 10228155
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.
Easwaran V; Song V; Polakis P; Byers S
J Biol Chem; 1999 Jun; 274(23):16641-5. PubMed ID: 10347231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
